Anthropic wants to develop its own drugs
6.2 relevance
Score Breakdown
technical depth 6
novelty 8
actionability 4
community 5
strategic 7
personal 8
Scored daily by a customisable AI persona to surface the most relevant engineering leadership news.
Anthropic's Claude Science is an AI workbench platform aligning with AI/ML and strategic industry moves.
Summary
Anthropic launched Claude Science, an AI workbench for scientists, and announced via life sciences head Eric Kauderer-Abrams plans to develop drugs for neglected diseases, putting it in direct competition with OpenAI, Google, Amazon, and AI-first drug companies. Experts caution that 'AI drug discovery' is a broad term applied across many stages, and Anthropic provided few specifics on execution.